Cartesian Therapeutics (RNAC) Institutional Ownership $16.57 -7.70 (-31.73%) (As of 12:18 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)CurrentInstitutional OwnershipPercentage86.95%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$318.39MNumber ofInstitutional Sellers(last 12 months)0 Get RNAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RNAC Institutional Buying and Selling by Quarter Ad Behind the Markets[Breaking] Classified Wargames Reveal Grave Threat from ChinaThe economic fallout could be devastating for unprepared investors. But sectors like aerospace & defense may see soaring demand. Don't be caught off guard - get the details on the weapons makers set to boom if war breaks out.Unlock the Top Military Industrial Stocks to Own Right Now >>> Cartesian Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098% 5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052% 5/10/2024Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172% 5/7/2024SG Americas Securities LLC47,134$31K0.0%N/A0.883% 5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261% 5/1/2024BNP Paribas Financial Markets59,125$38K0.0%N/A1.097% 4/23/2024Hall Laurie J Trustee52,775$34K0.0%N/A0.979% (Data available from 1/1/2016 forward) RNAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNAC shares? During the previous two years, the following institutional investors and hedge funds held shares of Cartesian Therapeutics shares: Artal Group S.A. ($5.94M), Vanguard Group Inc. ($4.11M), Delphi Financial Group Inc. ($430K), BNP Paribas Financial Markets ($38K), American International Group Inc. ($37K), and Hall Laurie J Trustee ($34K), and SG Americas Securities LLC ($31K).Learn more on RNAC's institutional investors. What percentage of Cartesian Therapeutics stock is owned by institutional investors? 86.95% of Cartesian Therapeutics stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings. Which institutional investors have been buying Cartesian Therapeutics stock? The following institutional investors have purchased Cartesian Therapeutics stock in the last 24 months: Artal Group S.A. ($9.14M), Vanguard Group Inc. ($6.32M), Delphi Financial Group Inc. ($660.85K), BNP Paribas Financial Markets ($59.13K), American International Group Inc. ($56.20K), Hall Laurie J Trustee ($52.78K), and SG Americas Securities LLC ($47.13K). How much institutional buying is happening at Cartesian Therapeutics? Institutional investors have bought a total of 16,327,836 shares in the last 24 months. This purchase volume represents approximately $318.39M in transactions. Related Companies: NAMS Institutional Ownership TARO Institutional Ownership AKRO Institutional Ownership KURA Institutional Ownership EWTX Institutional Ownership EVO Institutional Ownership MIRM Institutional Ownership DVAX Institutional Ownership RCUS Institutional Ownership SUPN Institutional Ownership This page (NASDAQ:RNAC) was last updated on 7/2/2024 by MarketBeat.com Staff From Our PartnersNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredThe Only Retirement Stock You'll Ever Need? Discover NowThere is a little region of America called Loudoun County. The value of each square mile has shot up close ...Behind the Markets | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredBiden’s inner circle turns against him?On August 19, the Democratic party will take the stage in Chicago and officially nominate their presidential c...Paradigm Press | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.